| Customization: | Available |
|---|---|
| CAS No.: | 108736-35-2 |
| Environmental Protection: | Yes |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name: Lanreotide Cas No.: 108736-35-2 Purity: 99.0%min. Appearance: White Crystalline Lyophilized Powder Package: 1mg,2mg,5mg.10mg Shelf Life :24Months Storage:Refrigeration keep dry and away from light. Introduction: SOMATULINE DEPOT (lanreotide) Injection 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL is a prolonged-release formulation for deep subcutaneous injection. It contains the drug substance lanreotide acetate, a synthetic octapeptide with a biological activity similar to naturally occurring somatostatin, water for injection and acetic acid (for pH adjustment). SOMATULINE DEPOT is indicated for the long-term treatment of acromegalic patients who have had an inadequate response to surgery and/orradiotherapy, or for whom surgery and/or radiotherapy is not an option. The goal of treatment in acromegaly is to reduce and insuli growth factor-1 levels to normal. Application: 1)Treatment of acromegaly (2)Treatment of certain tumors (3)Radiolabeling in Nuclear Medicine Imaging (4) Managing Bleeding Esophageal Varices (5)Obesity (6)Treatment of Gastrointestinal Fistula |
){kind=link}